Division of Cancer Etiology, Department of Population Sciences, City of Hope, Duarte, CA 91010, USA.
Blood. 2010 Jun 10;115(23):4820-3. doi: 10.1182/blood-2010-01-266775. Epub 2010 Apr 12.
Genome-wide association and candidate gene studies implicate different genetic variants within the 6p21 chromosomal region with different non-Hodgkin lymphoma (NHL) subtypes. Complementing these efforts, we conducted human leukocyte antigen (HLA) class I and class II genotyping among 610 NHL cases and 555 controls of non-Hispanic white descent from a US multicenter study. Allele-disease associations were assessed by logistic regression for NHL and its subtypes. Statistically significant associations between HLA and NHL subtypes include HLA-DRB10101 for follicular lymphoma (odds ratio [OR] = 2.14, P < .001), HLA-DRB10401 for diffuse large B-cell lymphoma (DLBCL; OR = 0.45, P = .006), and HLA-DRB1*13 and follicular lymphoma (OR = 0.48, P = .008). We further observed significant heterozygote advantage for HLA class I alleles and NHL, and particularly DLBCL (P trend = .01 for elevated risk with increasing number of homozygous alleles). Our results support a role for HLA in the etiology of NHL and its subtypes.
全基因组关联和候选基因研究表明,6p21 染色体区域内的不同遗传变异与不同的非霍奇金淋巴瘤 (NHL) 亚型有关。为了补充这些努力,我们在美国多中心研究中对 610 例 NHL 病例和 555 例非西班牙裔白人对照组进行了人类白细胞抗原 (HLA) Ⅰ类和Ⅱ类基因分型。通过逻辑回归评估 NHL 及其亚型的等位基因-疾病关联。HLA 与 NHL 亚型之间存在统计学显著关联,包括滤泡性淋巴瘤中的 HLA-DRB10101(比值比 [OR] = 2.14,P <.001)、弥漫性大 B 细胞淋巴瘤 (DLBCL) 中的 HLA-DRB10401(OR = 0.45,P =.006)以及 HLA-DRB1*13 和滤泡性淋巴瘤(OR = 0.48,P =.008)。我们还观察到 HLA Ⅰ类等位基因与 NHL 尤其是 DLBCL 之间存在显著的杂合子优势(随着同型等位基因数量的增加,风险升高的趋势 P 值为.01)。我们的结果支持 HLA 在 NHL 及其亚型的发病机制中的作用。